LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells

European Archives of Oto-Rhino-Laryngology (2021)Cite this article

Abstract

Purpose

The current study aimed to investigate the role of long intergenic noncoding 01433 (LINC01433) in the proliferation, migration and invasion of nasopharyngeal carcinoma (NPC).

Methods

Real-time quantitative PCR (RT-qPCR) was performed to determine the expressions of LINC01433 and miR-506-3p in NPC samples and cell lines. The effects of LINC01433 on cell proliferation, migration and invasion were measured by CCK-8, wound healing assay and Transwell, respectively. In addition, Pearson correlation analysis, starBase, RNA immunoprecipitation, luciferase assay, Western blot and functional experiments were conducted to detect and confirm the relationship between LINC01433 and miR-506-3p.

Results

LINC01433 level was noticeably elevated in NPC tissues and cell lines. As the expression of LINC01433 in 5-8F cells was the highest in NPC cell lines and the expression of LINC01433 in SUNE1 cells was the lowest, 5-8F and SUNE1 cells were therefore selected as the target cells for following experiments. Furthermore, miR-506-3p was predicted as the target of LINC01433, and the two were negatively correlated with each other. Interestingly, overexpression of LINC01433 promoted proliferation, migration and invasion of NPC cells, while miR-506-3p reversed such effects of LINC01433. Moreover, LINC01433 silencing had the opposite effects to LINC01433 overexpression. Furthermore, miR-506-3p overexpression inhibited the expressions of MMP2, N-cadherin, p-PI3K and p-Akt, and promoted the expressions of E-cadherin and TIMP-2, and partially reversed the role of LINC01433 in promoting cancer development.

Conclusion

The current findings reveal that LINC01433 regulates NPC cell biological progress through miR-506-3p.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Availability of data and materials

The analyzed data sets generated during the study are available from the corresponding author on reasonable request.

References

  1. 1.

    Paul P, Deka H, Malakar AK, Halder B, Chakraborty S (2018) Nasopharyngeal carcinoma: understanding its molecular biology at a fine scale. Eur J Cancer Prevent 27(1):33–41. https://doi.org/10.1097/cej.0000000000000314

    CAS  Article  Google Scholar 

  2. 2.

    Chua MLK, Wee JTS, Hui EP, Chan ATC (2016) Nasopharyngeal carcinoma. Lancet (Lond, Engl) 387(10022):1012–1024. https://doi.org/10.1016/s0140-6736(15)00055-0

    Article  Google Scholar 

  3. 3.

    Renganathan A, Felley-Bosco E (2017) Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol 1008:199–222. https://doi.org/10.1007/978-981-10-5203-3_7

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Cai Z, Xu K, Li Y, Lv Y, Bao J, Qiao L (2017) Long noncoding RNA in liver cancer stem cells. Discov Med 24(131):87–93

    PubMed  Google Scholar 

  5. 5.

    Li J, Li Z, Zheng W, Li X, Wang Z, Cui Y, Jiang X (2017) LncRNA-ATB: An indispensable cancer-related long noncoding RNA. Cell Prolif 50:6. https://doi.org/10.1111/cpr.12381

    CAS  Article  Google Scholar 

  6. 6.

    Wang J, Su Z, Lu S, Fu W, Liu Z, Jiang X, Tai S (2018) LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta 485:229–233. https://doi.org/10.1016/j.cca.2018.07.004

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Huang HW, Xie H, Ma X, Zhao F, Gao Y (2017) Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer. Eur Rev Med Pharmacol Sci 21(20):4529–4535

    PubMed  Google Scholar 

  8. 8.

    Geng YJ, Xie SL, Li Q, Ma J, Wang GY (2011) Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 39(6):2119–2128. https://doi.org/10.1177/147323001103900608

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Zhang R, Xia Y, Wang Z, Zheng J, Chen Y, Li X, Wang Y, Ming H (2017) Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem Biophys Res Commun 490(2):406–414. https://doi.org/10.1016/j.bbrc.2017.06.055

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    He R, Hu Z, Wang Q, Luo W, Li J, Duan L, Zhu YS, Luo DX (2017) The role of long non-coding RNAs in nasopharyngeal carcinoma: as systemic review. Oncotarget 8(9):16075–16083. https://doi.org/10.18632/oncotarget.14211

    Article  PubMed  Google Scholar 

  11. 11.

    Sun Q, Liu H, Li L, Zhang S, Liu K, Liu Y, Yang C (2015) Long noncoding RNA-LET, which is repressed by EZH2, inhibits cell proliferation and induces apoptosis of nasopharyngeal carcinoma cell. Med Oncol (Northwood, Lond, Engl) 32(9):226. https://doi.org/10.1007/s12032-015-0673-0

    CAS  Article  Google Scholar 

  12. 12.

    Yang QQ, Deng YF (2015) Genome-wide analysis of long non-coding RNA in primary nasopharyngeal carcinoma by microarray. Histopathology 66(7):1022–1030. https://doi.org/10.1111/his.12616

    Article  Google Scholar 

  13. 13.

    Nie Y, Liu X, Qu S, Song E, Zou H, Gong C (2013) Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci 104(4):458–464. https://doi.org/10.1111/cas.12092

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X (2001) The sequence of the human genome. Science 291(5507):1304–1351. https://doi.org/10.1126/science.1058040

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Qian B, Wang X, Mao C, Jiang Y, Shi Y, Chen L, Liu S, Wang B, Pan S, Tao Y, Shi H (2018) Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer. Thorac Cancer 9(5):589–597. https://doi.org/10.1111/1759-7714.12623

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Wu M, Wu W, Ding J, Yang J (2019) LINC01433/miR-2116-3p/MYC feedback loop promotes cell proliferation, migration, and the epithelial-mesenchymal transition in breast cancer. Cancer Biotherapy Radiopharmaceut 34(6):388–397. https://doi.org/10.1089/cbr.2019.2772

    CAS  Article  Google Scholar 

  17. 17.

    Zhang A, Xu M, Mo YY (2014) Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol 6(3):181–191. https://doi.org/10.1093/jmcb/mju013

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Ballantyne MD, McDonald RA, Baker AH (2016) lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther 99(5):494–501. https://doi.org/10.1002/cpt.355

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Kong YG, Cui M, Chen SM, Xu Y, Xu Y, Tao ZZ (2018) LncRNA-LINC00460 facilitates nasopharyngeal carcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6. Gene 639:77–84. https://doi.org/10.1016/j.gene.2017.10.006

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Huang H, Bu YZ, Zhang XY, Liu J, Zhu LY, Fang Y (2019) LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis. J Cell Physiol 234(5):6116–6124. https://doi.org/10.1002/jcp.27366

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Rio DC, Ares M Jr, Hannon GJ (2010) Nilsen TW (2010) Purification of RNA using TRIzol (TRI reagent). Cold Spring Harbor Protocols 6:5439. https://doi.org/10.1101/pdb.prot5439

    Article  Google Scholar 

  22. 22.

    Xie L, Hu Z, Wang X, Li Z (2013) Expression of long noncoding RNA MALAT1 gene in human nasopharyngeal carcinoma cell lines and its biological significance. J Southern Med Univ 33(5):692–697

    CAS  Google Scholar 

  23. 23.

    Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao Q, Chen P, Shi L, Lian Y, Jing Y, Tang K, Li Z, Zhou Y, Zhou M, Xiang B, Li X, Yang J, Xiong W, Li G, Zeng Z (2015) Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget 6(24):20404–20418. https://doi.org/10.18632/oncotarget.4057

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, Waye MM (2015) The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6(26):22513–22525. https://doi.org/10.18632/oncotarget.4154

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Zhang W, Wang L, Zheng F, Zou R, Xie C, Guo Q, Hu Q, Chen J, Yang X, Yao H, Song E, Xiang Y (2015) Long noncoding RNA expression signatures of metastatic nasopharyngeal carcinoma and their prognostic value. Biomed Res Int 2015:618924. https://doi.org/10.1155/2015/618924

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Zhang S, Zhong G, He W, Yu H, Huang J, Lin T (2016) lncRNA up-regulated in nonmuscle invasive bladder cancer facilitates tumor growth and acts as a negative prognostic factor of recurrence. J Urol 196(4):1270–1278. https://doi.org/10.1016/j.juro.2016.05.107

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Nie GH, Li Z, Duan HF, Luo L, Hu HY, Yang WQ, Nie LP, Zhu RF, Chen XF, Zhang W (2017) lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma. Oncol Lett 13(6):4487–4492. https://doi.org/10.3892/ol.2017.6021

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Ma DD, Yuan LL, Lin LQ (2017) LncRNA HOTAIR contributes to the tumorigenesis of nasopharyngeal carcinoma via up-regulating FASN. Eur Rev Med Pharmacol Sci 21(22):5143–5152. https://doi.org/10.26355/eurrev_201711_13831

    Article  PubMed  Google Scholar 

  29. 29.

    Zhang C, Qian H, Liu K, Zhao W, Wang L (2019) A Feedback loop regulation of LINC01433 and YAP promotes malignant behavior in gastric cancer cells. OncoTargets Therapy 12:7949–7962. https://doi.org/10.2147/OTT.S222903

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Qadir MI, Faheem A (2017) miRNA: a diagnostic and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene Expr 27(3):197–204. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2017019494

    Article  PubMed  Google Scholar 

  31. 31.

    Puik JR, Meijer LL, Le Large TY, Prado MM, Frampton AE, Kazemier G, Giovannetti E (2017) miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. Pharmacogenomics 18(14):1343–1358. https://doi.org/10.2217/pgs-2017-0010

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Yu F, Lv M, Li D, Cai H, Ma L, Luo Q, Yuan X, Lv Z (2015) MiR-506 over-expression inhibits proliferation and metastasis of breast cancer cells. Med Sci Monitor 21:1687–1692. https://doi.org/10.12659/msm.893522

    CAS  Article  Google Scholar 

  33. 33.

    Yao J, Qin L, Miao S, Wang X, Wu X (2016) Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1. Oncol Lett 12(3):1840–1848. https://doi.org/10.3892/ol.2016.4827

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Luo Y, Sun R, Zhang J, Sun T, Liu X, Yang B (2015) miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma. Am J Transl Res 7(10):2007–2014

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Erice O, Munoz-Garrido P, Vaquero J, Perugorria MJ, Fernandez-Barrena MG, Saez E, Santos-Laso A, Arbelaiz A, Jimenez-Aguero R, Fernandez-Irigoyen J, Santamaria E, Torrano V, Carracedo A, Ananthanarayanan M, Marzioni M, Prieto J, Beuers U, Oude Elferink RP, LaRusso NF, Bujanda L, Marin JJG, Banales JM (2018) MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation. Hepatol (Baltim) 67(4):1420–1440. https://doi.org/10.1002/hep.29533

    CAS  Article  Google Scholar 

  36. 36.

    Gong M, Chen C, Zhao H, Sun M, Song M (2018) miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo. Neoplasma 65(3):331–338. https://doi.org/10.4149/neo_2018_170112N25

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Liu G, Sun Y, Ji P, Li X, Cogdell D, Yang D, Parker Kerrigan BC, Shmulevich I, Chen K, Sood AK, Xue F, Zhang W (2014) MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol 233(3):308–318. https://doi.org/10.1002/path.4348

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Zhang Z, Ma J, Luan G, Kang L, Su Y, He Y, Luan F (2015) MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma. PLoS ONE 10(4):e0122851. https://doi.org/10.1371/journal.pone.0122851

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Li J, Ju J, Ni B, Wang H (2016) The emerging role of miR-506 in cancer. Oncotarget 7(38):62778–62788. https://doi.org/10.18632/oncotarget.11294

    Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Liang TS, Zheng YJ, Wang J, Zhao JY, Yang DK, Liu ZS (2019) MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/beta-catenin signaling pathway by down-regulating LHX2. J Exp Clin Cancer Res 38(1):97. https://doi.org/10.1186/s13046-019-1023-4

    Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Feng X, Zhang C, Zhu L, Zhang L, Li H, He L, Mi Y, Wang Y, Zhu J, Bu Y (2017) DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma. Oncotarget 8(38):63605–63619. https://doi.org/10.18632/oncotarget.18868

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Lawicki S, Zajkowska M, Glazewska EK, Bedkowska GE, Szmitkowski M (2017) Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients. Biomarkers 22(2):157–164. https://doi.org/10.1080/1354750x.2016.1252955

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Shrestha B, Bajracharya D, Byatnal AA, Kamath A, Radhakrishnan R (2017) May High MMP-2 and TIMP-2 expressions increase or decrease the aggressivity of oral cancer? Pathol Oncol Res 23(1):197–206. https://doi.org/10.1007/s12253-016-0149-3

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Yi GZ, Feng WY, Zhou Q, Liu YW, Qi ST (2017) The impact of MMP-2 and its specific inhibitor TIMP-2 expression on the WHO grade and prognosis of gliomas in Chinese population: a meta-analysis. Mol Neurobiol 54(1):22–30. https://doi.org/10.1007/s12035-015-9539-x

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Wang T, Hou J, Jian S, Luo Q, Wei J, Li Z, Wang X, Bai P, Duan B, Xing J, Cai J (2018) miR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth. J Cancer 9(20):3776–3786. https://doi.org/10.7150/jca.26263

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Lei H, Gao Y, Xu X (2017) LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin 49(7):588–597. https://doi.org/10.1093/abbs/gmx047

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Derycke LD, Bracke ME (2004) N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Develop Biol 48(5–6):463–476. https://doi.org/10.1387/ijdb.041793ld

    CAS  Article  Google Scholar 

  48. 48.

    Blaschuk OW (2015) N-cadherin antagonists as oncology therapeutics. Philos Trans R Soc Lond B Biol Sci 370(1661):20140039. https://doi.org/10.1098/rstb.2014.0039

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Petrova YI, Schecterson L, Gumbiner BM (2016) Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell 27(21):3233–3244. https://doi.org/10.1091/mbc.E16-01-0058

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Zhu Y, Yan L, Zhu W, Song X, Yang G, Wang S (2019) MMP2/3 promote the growth and migration of laryngeal squamous cell carcinoma via PI3K/Akt-NF-kappaB-mediated epithelial-mesenchymal transformation. J Cell Physiol. https://doi.org/10.1002/jcp.28242

    Article  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Kolude B, Adisa AO, Lawal AO, Adeyemi BF, Akinyamoju AO (2015) Stoichiometric expression of MMP-2/TIMP-2 in benign and malignant tumours of the salivary gland. Tumour Biol 36(4):2351–2357. https://doi.org/10.1007/s13277-014-2842-8

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Xia P, Xu XY (2015) PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res 5(5):1602–1609

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the Scientific Research Project of Zhejiang Educational Committee [Grant no. Y201636243].

Author information

Affiliations

  1. Department of Otorhinolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No.3, East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China

    Mingguang Zhou, Zhihuai Dong, Sunhong Hu & Mang Xiao

Authors
  1. Mingguang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhihuai Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunhong Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mang Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Substantial contributions to conception and design: MZ. Data acquisition, data analysis and interpretation: ZD, SH, MX. Drafting the article or critically revising it for important intellectual content: MZ. Final approval of the version to be published: All authors. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved: All authors.

Corresponding author

Correspondence to Mingguang Zhou.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 19 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhou, M., Dong, Z., Hu, S. et al. LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells. Eur Arch Otorhinolaryngol (2021). https://doi.org/10.1007/s00405-021-06607-w

Download citation

Keywords

  • LINC01433
  • miR-506-3p
  • Nasopharyngeal carcinoma
  • Proliferation
  • Migration